Relation of low vitamin D to nonvalvular persistent atrial fibrillation in Chinese patients

Wei Ren Chen1, Zhi Ying Liu, Yang Shi

  • 1Department of Cardiology, South-Building, PLA General Hospital, Beijing, China.

Insights

Low vitamin D levels are linked to a higher risk of atrial fibrillation (AF). This study found lower vitamin D in AF patients, suggesting a potential role in AF development.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Low vitamin D status is a known risk factor for cardiovascular diseases.
  • Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia globally.

Purpose of the Study:

  • To investigate the association between low vitamin D levels and the occurrence of atrial fibrillation (AF).

Main Methods:

  • A comparative analysis was conducted on 162 Chinese patients diagnosed with nonvalvular persistent AF and 160 healthy controls.
  • Serum 25-hydroxyvitamin D [25(OH)D] levels were measured using a chemiluminescence assay.

Main Results:

  • Patients with AF exhibited significantly lower serum 25(OH)D levels compared to controls (18.5 vs. 21.4 ng/mL).
  • Elevated high-sensitivity C-reactive protein (hsCRP) and larger left atrial diameter were observed in the AF group.
  • Serum 25(OH)D showed a negative correlation with left atrial diameter, hsCRP, and pulmonary artery systolic pressure.

Conclusions:

  • Low vitamin D levels are significantly associated with atrial fibrillation.
  • Vitamin D deficiency may play a role in the pathogenesis of AF.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
1.2K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
500
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
2.8K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
627